Diabetes incidence before and after COVID-19 vaccination - Results from the German Disease Analyzer database.

COVID-19 Diabetes mellitus SARS-CoV-2 Vaccination

Journal

Vaccine: X
ISSN: 2590-1362
Titre abrégé: Vaccine X
Pays: England
ID NLM: 101748769

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 13 04 2023
revised: 07 06 2023
accepted: 19 06 2023
medline: 14 7 2023
pubmed: 14 7 2023
entrez: 14 7 2023
Statut: epublish

Résumé

We investigated whether COVID-19 vaccination had an impact on diabetes risk. We used data of 6,198 patients (mean age 64.3 years) from the nationwide Disease Analyzer database, a representative panel of physicians' practices in Germany. Patients received their first COVID-19 vaccination between 1 April 2021 and 31 March 2022, and all were newly diagnosed with diabetes within 183 days before or after this vaccination. Incident rates of diabetes after vaccination were compared to incident rates before vaccination. The incidence rate of diabetes was lower after vaccination than before vaccination (incidence rate ratio = 0.79, 95% confidence interval: 0.75-0.83). The number of incident cases of diabetes was not greater in 2021 than in 2019. Our study did not confirm an increased risk of diabetes after COVID-19 vaccination. Further studies are needed to show whether the vaccination may be associated with a reduced diabetes risk.

Identifiants

pubmed: 37448976
doi: 10.1016/j.jvacx.2023.100336
pii: S2590-1362(23)00077-3
pmc: PMC10290168
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100336

Informations de copyright

© 2023 The Author(s).

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Croat Med J. 2022 Dec 31;63(6):508-514
pubmed: 36597562
Diabetes Metab Syndr. 2021 Mar-Apr;15(2):505-508
pubmed: 33662837
Diabetes Care. 2022 Feb 1;45(2):e24-e26
pubmed: 34848490
PLoS Med. 2022 Jul 19;19(7):e1004052
pubmed: 35853019
Int J Clin Pharmacol Ther. 2018 Oct;56(10):459-466
pubmed: 30168417
Acta Diabetol. 2022 Dec;59(12):1609-1614
pubmed: 36069940
Diabetologia. 2022 Jun;65(6):949-954
pubmed: 35292829
Lancet Diabetes Endocrinol. 2020 Oct;8(10):813-822
pubmed: 32798472
JAMA Netw Open. 2023 Feb 1;6(2):e2255965
pubmed: 36787145
Lancet Diabetes Endocrinol. 2022 May;10(5):311-321
pubmed: 35325624
Lancet Diabetes Endocrinol. 2022 Aug;10(8):561-570
pubmed: 35636440
Front Endocrinol (Lausanne). 2022 Nov 10;13:1027047
pubmed: 36440218
BMJ Qual Saf. 2022 Jul;31(7):503-514
pubmed: 34642228
Int J Clin Pharmacol Ther. 2009 Oct;47(10):617-26
pubmed: 19825325
Diabetes Res Clin Pract. 2023 Jul;201:110723
pubmed: 37209876
Diabet Med. 2022 Apr;39(4):e14774
pubmed: 34936128

Auteurs

Bernd Kowall (B)

Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Germany.

Karel Kostev (K)

Epidemiology, IQVIA, Frankfurt/Main, Germany.

Rüdiger Landgraf (R)

German Diabetes Foundation, Munich, Germany.

Hans Hauner (H)

Institute of Nutritional Medicine, School of Medicine, Technical University of Munich, Munich, Germany.

Ralf Bierwirth (R)

MVZ Praxis für Diabetologie, Essen, Germany.

Oliver Kuss (O)

Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Germany.
Centre for Health and Society, Faculty of Medicine, Heinrich Heine University Düsseldorf, Germany.

Wolfgang Rathmann (W)

Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Germany.

Classifications MeSH